Paper II: Henrik Brun, Henrik Holmstrøm, Erik Thaulow, Jan Kristian Damås, Arne Yndestad,
Pål Aukrust and Thor Ueland. Patients with pulmonary hypertension related to congenital …

Objective. We examined inflammatory mediators in patients with pulmonary hypertension
related to congenital systemic‐to‐pulmonary shunts and the change in these markers during …

Introduction 258 Definition 258 Epidemiology and classification 259 Pathobiology and
pathophysiology 259 Clinical presentation 261 Investigations 261 Treatment 263 Acute …

Objective. The hypothesis was that the levels of circulating inflammatory mediators are
related to the degree of volume and pressure stress on the pulmonary vasculature in …

Pulmonary arterial hypertension is a significant complication of congenital heart disease,
which carries a recognized risk of morbidity and mortality. There have been remarkable …

Pulmonary arterial hypertension (PAH) is a common complication of congenital heart
disease (CHD), particularly when a significant left-to-right (systemic-to-pulmonary) shunt …

Congenital heart disease (CHD) is one of the most common congenital malformations,
occurring in about 0.8% of newborns. Some of the most common congenital heart defects …

(Introduction) of coexisting congenital systemic-pulmonary (SP) shunting in small children in
developed countries, which is a diagnostic challenge requiring further investigation …

Pulmonary hypertension associated with congenital systemic-to-pulmonary shunts has been
classified, in the Evian-Venice classification, as Pulmonary Arterial Hypertension, which …

Objective To compare survival of patients with newly diagnosed pulmonary arterial
hypertension associated with congenital heart disease (PAH-CHD) according to various …